Martine Rothblatt and SiriusXM: Career, Compensation, and Board Role
Martine Rothblatt is a co-founder of Sirius Satellite Radio, which merged with XM Satellite Radio in 2008 to form SiriusXM. She later served as a non-executive director and board member of SiriusXM. Her work helped shape early satellite radio technology and company strategy before she shifted focus to biotech and other ventures. Forbes has covered her transition from satellite communications to life sciences.
Rothblatt's compensation and equity stakes in SiriusXM have been documented in company proxy filings and investor communications. Her board tenure coincided with major changes in satellite radio subscriptions, streaming competition, and industry consolidation. Public data shows she remained associated with SiriusXM as an influential early figure while building other companies.
United Therapeutics, Lung Biotechnology, and Pharma Leadership
Rothblatt founded United Therapeutics in 1996 after her daughter was diagnosed with pulmonary arterial hypertension. The company develops therapies including Remodulin and Tyvaso, and it has expanded into lung biotechnology and xenotransplantation research. SEC filings provide details on United Therapeutics revenue, clinical trials, and executive compensation.
Under Rothblatt's leadership, United Therapeutics has grown into a publicly traded biotech company focused on rare lung diseases and organ manufacturing. The company's pipeline includes programs for bioengineered lungs and other technologies aimed at addressing donor organ shortages. Bloomberg tracks United Therapeutics' market cap, pipeline milestones, and financial performance.
Satellite Radio Industry, SiriusXM Market Position, and Legacy
SiriusXM remains one of the largest satellite radio providers in North America, offering subscriptions, streaming, and exclusive content. The company serves millions of subscribers and competes with digital streaming platforms. SiriusXM Investor Relations publishes earnings reports, subscriber counts, and strategic updates.
Rothblatt's early advocacy for satellite radio helped create the foundation for the current SiriusXM ecosystem. Her broader work in technology, law, and medicine reflects a pattern of building companies around unmet needs. Bloomberg profiles describe her as a serial entrepreneur with ventures spanning telecom, biotech, and aerospace.